Idarubicin Injection 5 mg/5 mL (5)

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

idarubicin hydrochloride, Quantity: 1 mg/mL

Verfügbar ab:

Pfizer (Perth) Pty Ltd

Darreichungsform:

Injection, solution

Zusammensetzung:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

Verabreichungsweg:

Intravenous

Einheiten im Paket:

1 X 5 mL

Verschreibungstyp:

(S1) This Schedule is intentionally blank

Anwendungsgebiete:

Acute myeloid leukaemia in combination with other cytotoxic agents. Acute lymphoblastic leukaemia as a reserve medicinal product in combination with other cytotoxic agents.

Produktbesonderheiten:

Visual Identification: Plastic vials containing a red-orange, clear, mobile solution; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Berechtigungsstatus:

Listed (Export Only)

Berechtigungsdatum:

2023-03-03